surpass cvot tirzepatide Efficacy and safety of in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial ACC 26: SURPASS-CVOT - Tirzepatide

After excluding 134 randomized in error, 6,586 received tirzepatide and 6,579 received dulaglutide

This is an important point for readers because people often assume that if a medicine is talked about in the news, it must now be easy to get from a GP

Tuesday 21 October (Central Daylight Time six hours behind UK time) Core Interactive Session Translating OSA Endophenotyping into Clinical Trials (91510:15am CDT) Rapid-Fire Oral: SynAIRgy Phase 3 Trial 1:451:50pm CDT Poster: LunAIRo 51-week Phase 3 Trial 1:452:30pm CDT Additional posters explore the impact of OSA on productivity and the economic burden of fatigue and daytime sleepiness

Five minutes if you can manage it

Patients should maintain adequate hydration and seek prompt medical advice if persistent vomiting, diarrhoea, or signs of dehydration occur

To keep the discounted pricing, you must complete your refills within 45 days